全文获取类型
收费全文 | 71072篇 |
免费 | 5996篇 |
国内免费 | 3236篇 |
专业分类
耳鼻咽喉 | 196篇 |
儿科学 | 1327篇 |
妇产科学 | 829篇 |
基础医学 | 12687篇 |
口腔科学 | 739篇 |
临床医学 | 5535篇 |
内科学 | 16731篇 |
皮肤病学 | 1072篇 |
神经病学 | 2647篇 |
特种医学 | 1293篇 |
外国民族医学 | 9篇 |
外科学 | 3876篇 |
综合类 | 10539篇 |
现状与发展 | 19篇 |
预防医学 | 5999篇 |
眼科学 | 485篇 |
药学 | 8807篇 |
18篇 | |
中国医学 | 3532篇 |
肿瘤学 | 3964篇 |
出版年
2023年 | 786篇 |
2022年 | 1840篇 |
2021年 | 2281篇 |
2020年 | 2141篇 |
2019年 | 2382篇 |
2018年 | 2272篇 |
2017年 | 2238篇 |
2016年 | 2602篇 |
2015年 | 2863篇 |
2014年 | 4651篇 |
2013年 | 4845篇 |
2012年 | 4777篇 |
2011年 | 5089篇 |
2010年 | 4120篇 |
2009年 | 3921篇 |
2008年 | 3872篇 |
2007年 | 3759篇 |
2006年 | 3427篇 |
2005年 | 2927篇 |
2004年 | 2424篇 |
2003年 | 2102篇 |
2002年 | 1710篇 |
2001年 | 1497篇 |
2000年 | 1155篇 |
1999年 | 1010篇 |
1998年 | 925篇 |
1997年 | 767篇 |
1996年 | 648篇 |
1995年 | 661篇 |
1994年 | 565篇 |
1993年 | 462篇 |
1992年 | 440篇 |
1991年 | 349篇 |
1990年 | 318篇 |
1989年 | 285篇 |
1988年 | 238篇 |
1987年 | 205篇 |
1986年 | 170篇 |
1985年 | 443篇 |
1984年 | 460篇 |
1983年 | 371篇 |
1982年 | 379篇 |
1981年 | 316篇 |
1980年 | 292篇 |
1979年 | 261篇 |
1978年 | 205篇 |
1977年 | 159篇 |
1976年 | 176篇 |
1975年 | 153篇 |
1974年 | 126篇 |
排序方式: 共有10000条查询结果,搜索用时 766 毫秒
131.
Abstract The outcome of OLT for HBV-related liver disease is dependent on the prevention of allograft re-infection. Over the past decade, major advances have been made in the management of HBV transplant candidates. The advent of long-term hepatitis B immune globulin (HBIG) administration as a prophylaxis against HBV recurrence, and the introduction of new antiviral agents against HBV infection, such as lamivudine (LAM), were a major breakthrough in the management of these patients. Results of OLT for HBV infection are similar to those achieved with other indications. Pre-OLT antiviral treatment such as LAM can suppress HBV replication before OLT and thus decrease the risk of re-infection of the graft. Combination prophylaxis with LAM and HBIG after transplantation highly effectively reduces the rate of HBV re-infection, even in HBV replicative cirrhotic, patients. The optimal HBIG protocol in the LAM era is yet to be defined: dosing of HBIG, routes of administration, and possibility of stopping HBIG. Several antiviral drugs have been developed for the management of HBV infection on the graft, so outcome is currently good. 相似文献
132.
Summary: To investigate the effect of N-tosyl-L-phenylalanylchloromethyl ketone (TPCK) on tumor necrosis factor-alpha-induced NF-κB activation and apoptosis in U937 cell line, changes and subcellular localization of NF-κB/p65 and IκB-α were observed by fluorescencemicroscopy and expression and degradation of IκB-α by flow cytometry. The apoptosis of U937 cells was measured by flow cytometry and electrophoresis of DNA. Immunolfluorescence assay showed that NF-κB/p65,IκB-α only localized in cytoplasm. After TNF-α stimulation, p65 was localized only in nuclei, and IκB-α was only localized in cytoplasm and decreased. The changes of TNF-α stimulation were specifically inhibited by TPCK. Flow cytometry also revealed the downregulation of IκB-α protein during TNF-α-induced apoptosis and the down-regulation was specifically inhibited by TPCK. Flow cytometry also showed the apoptosis of U937 cells after TNF-α induction. DNA ladder can be detected in cells treated by TNF-α. It is concluded that degradation of IκB-α protein and NF-κB/p65 translocation occur during TNF-α-induced apoptosis of U937 cells, suggesting the activation of NF-κB.TPCK-sensitive protease plays an important role in the degradation of IκB-α protein induced by TNF-α in U937 cells. TPCK sensitive protease also plays an important role in the apoptosis of U937 cells induced by TNF-α. 相似文献
133.
血清乙型肝炎病毒标志物不同表现模式及肝功能异常对肾移植受者存活率的影响 总被引:1,自引:0,他引:1
目的 探讨血清乙型肝炎病毒标志物不同表现模式对肾移植受者长期存活的影响。方法 对 62例血清乙型肝炎病毒标志物阳性者及 1 96例血清乙型肝炎病毒标志物全阴性者肾移植术后的肝功能、人肾均存活的存活率等指标进行随访和回顾性分析。结果 术后早期血清乙型肝炎病毒标志物阳性组与血清乙型肝炎病毒标志物阴性组比较 ,肝功能异常发生率的差异无显著性 (P >0 .0 5) ;术后中远期 ,HBsAg、HBeAg及抗 HBc阳性者的肝功能受损率明显高于血清乙型肝炎病毒标志物阴性组及HBsAg、抗 HBe、抗 HBc阳性者 (P <0 .0 5) ,其人肾均存活的存活率也最低 (P <0 .0 5)。结论 对HBsAg、抗 HBe及抗 HBc阳性者进行肾移植应慎重 ,而HBsAg、HBeAg及抗 HBc阳性者则不适宜接受肾移植 相似文献
134.
135.
Fumonisins as a possible contributory risk factor for primary liver cancer: A 3-year study of corn harvested in Haimen, China, by HPLC and ELISA 总被引:13,自引:0,他引:13
Y. Ueno K. Iijima S.-D. Wang Y. Sugiura M. Sekijima T. Tanaka C. Chen S.-Z. Yu 《Food and chemical toxicology》1997,35(12):1143-1150
Employing HPLC fluorometry, gas-liquid chromatography (GLC) and a novel enzymelinked immunosorbent assay (ELISA) based on a monoclonal antibody, 40 corn samples, each collected in 1993 from agricultural stocks for human consumption in Haimen (Jiangsu County) and Penlai (Shandong Province), high- and low-risk areas for primary liver cancer (PLC) in China, respectively, were analysed for fumonisins (FBs), aflatoxins (AFs) and trichothecenes. Levels and positive rates of FBs and deoxynivalenol (DON) were significantly higher in Haimen than in Penlai. ELISA of the 40 corn samples harvested in the two areas in 1994 revealed that FB contamination levels and rates in these areas were comparable to those observed in 1993 in Haimen. ELISA analysis of 1993 and 1994 products revealed a wide occurrence of AFB1 but the positive rates as well as levels were not significantly different between these areas. ELISA of the same sample number of corn harvested in 1995 revealed that FB contamination in Haimen was significantly higher than in Penlai. These 3-yearly surveys of corn samples (240 in total) demonstrated that corn harvested in Haimen was highly contaminated with FBs and that the contamination level, as well as positive rate in 1993 and 1995, were 10–50-fold higher than those in Penlai, suggesting FBs as a risk factor for promotion of PLC in endemic areas, along with the trichothecene DON. Co-contamination with AFs, potent hepatocarcinogens, was assumed to play an important role in the initiation of hepatocarcinogenesis. 相似文献
136.
P. V. Luoma A. Rautio J. Steng»rd E. A. Sotaniemi J. Marniemi 《European journal of clinical pharmacology》1990,38(6):625-627
Summary Serum high density lipoprotein (HDL) subfractions HDL2 and HDL3, apolipoproteins, and plasma antipyrine clearance (AP-CL) rate, an index of liver microsomal enzyme activity, were determined in 21 healthy subjects. High HDL cholesterol and HDL2 cholesterol concentrations and HDL cholesterol/cholesterol and HDL2/HDL3 cholesterol ratios were associated with high AP-CL. Phenobarbital enhanced antipyrine elimination and increased the apolipoprotein A-I/A-II ratio. Subjects who had high AP-CL had a more antiatherogenic HDL subfraction and apolipoprotein profile than those with low AP-CL. 相似文献
137.
以地高辛甙元随机引物法标记HBV-DNA探针,以此探针检测慢性乙型肝炎患者的血清、肝组织,同时以ELISA法检测血清HBeAg、HBcAb。结果:血清NBeAg阳性率27%(10/37),血清HBV-DNA检出率57.1%(20/35),两者有显著性差异。血清HBcAb阳性率78.4%(29/37),肝组织HBV-DNA检出率83.8%(31/37),两者无显著性差异。血清与肝组织HBV-DNA检出率有显著性差异。提示:血清HBV-DNA检测是较HBeAg更为准确客观反映血液带毒状况的指标。而准确反映肝脏带毒状况的指标是肝组织HBV-DNA检测。当HBeAg阴转,血清HBV-DNA阴性而肝组织HBV-DNA阳性时,需注意肝硬化及肝癌的发生。 相似文献
138.
目的:了解DNA疫苗在BALB/c小鼠体内的生物分布情况,建立DNA疫苗体内生物分布情况研究方法。方法:乙肝核酸疫苗(HBV DNA)经^32P标记、分离、纯化、鉴定后,胫前肌注射给药,结合三氯乙酸(TCA)沉淀,研究肌注乙肝核酸疫苗后BALB/c小鼠体内的生物分布情况。结果:质粒DNA疫苗除注射局部肌肉分布较多外,其他一些重要组织也有分布,其中腺体组织(肾上腺、胰腺、胸腺)中的浓度最高,其次为排泄物(尿、肠内粪),脑组织中浓度最低。各组织中可沉淀放射性按血浆浓度时间曲线下面积(AUC)从高到低排列依次为胸腺、肾上腺、膀胱、生殖腺、脂肪、肠内粪、胰腺、颌下腺、脾、小肠、眼球、肝、肠内容、肾、甲状腺、肺、淋巴结、对侧肌肉、心脏和脑。结论:^32P标记DNA疫苗后各组织β计数结合三氦乙酸沉淀法研究核酸疫苗生物分布情况,方法灵敏、可靠,易于分析。 相似文献
139.
用多粘菌素B琼脂糖亲和层析法清除内毒素,结果表明:5ml多粘菌素B层析柱的总吸附内毒素能力为450 μg,用此法可完全清除体液或各种液体中的内毒素,对血清及腹水中的内毒素也有明显的吸附作用,而其他各种主要成分(除内毒素外)经过处理后无明显改变。去氧胆酸是一种强有力的去污剂,可使已饱和的柱子复活,复活率达85%左右。该方法有简便,可靠,吸附能力大,柱子的复活率高等优点。本方法的建立为内毒素血症的治疗展示了新的前景。 相似文献
140.
应用放射免疫分析法测定慢性活动性肝炎(CAH)和慢性迁延性肝炎(CPH)病人及健康人血清中游离白细胞介素2受体(fIL2R)水平,CAH和CPH病人的cpm分别是2326±617及1277±397,健康人仅为343±213。结果发现:CAH和CPH病人血清中fIL2R水平均显著高于健康人(P<0.01);CAH病人血清中fIL2R水平高于CPH病人(P<0.01)。提示,慢性乙型肝炎病人血清中fIL2R水平升高可能与其免疫应答异常及炎症活动性有关。 相似文献